432
Participants
Start Date
November 30, 2002
Primary Completion Date
November 30, 2010
Study Completion Date
January 31, 2011
buspirone hydrochloride
The dose of buspirone will be 10 mg taken by mouth at bedtime for 3 days, then twice each day, in the morning and at bedtime for the remainder of the 28 day study period
Placebo
Placebo
CCOP - Hematology-Oncology Associates of Central New York, East Syracuse
CCOP - Upstate Carolina, Spartanburg
CCOP - Greenville, Greenville
CCOP - Dayton, Dayton
CCOP - Marshfield Clinic Research Foundation, Marshfield
CCOP - Evanston, Evanston
CCOP - Central Illinois, Decatur
CCOP - Kansas City, Kansas City
CCOP - Nevada Cancer Research Foundation, Las Vegas
CCOP - Columbia River Oncology Program, Portland
MBCCOP - University of Illinois at Chicago, Chicago
CCOP - Wichita, Wichita
CCOP - Kalamazoo, Kalamazoo
CCOP - Southeast Cancer Control Consortium, Goldsboro
CCOP - Northwest, Tacoma
National Cancer Institute (NCI)
NIH
University of Rochester
OTHER